Randomized Controlled Trial of Labetalol Versus Hydralazine for Severe Hypertension in Obstetric Patients.

NCT02050529 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

190

Enrollment

OTHER

Sponsor class

Conditions

Hypertension, Pregnancy Induced
Hydralazine Adverse Reaction
Pre-eclampsia
Pre-eclampsia Superimposed Pre-existing Hypertension

Interventions

DRUG: Labetalol
DRUG: Hydralazine

Sponsor

Dow University of Health Sciences